As functional mushroom supplements proliferate in pharmacies and online retailers, clinical evidence remains highly selective. Turkey Tail PSK uniquely stands out with Cochrane-reviewed cancer survival data and over 40 years of integration into standard Japanese oncology care. In stark contrast, popular species including lion’s mane, reishi, and cordyceps lack completed human clinical trials, and their bioavailability through standard oral digestion remains unknown. Quality control presents another critical issue: many commercial products contain 30–60% rice starch filler with minimal bioactive compounds, making label scrutiny essential. Healthcare providers should counsel patients to distinguish between evidence-backed formulations and marketing-driven claims. For those considering functional mushroom supplements, verifying bioactive concentrations, seeking third-party certification, and consulting clinical evidence before purchase are prudent steps toward informed decision-making.
Was this article helpful?

